Structural contributions to multidrug recognition in the multidrug resistance (MDR) gene regulator, BmrR

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 27, 2011, Pages 11046-11051

  Bachas, Sharrol ^a   Eginton, Christopher ^a   Gunio, Drew ^a   Wade, Herschel ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ligand binding; Ligand responsive transcription factor; Molecular recognition; Multidrug resistance; Multispecificity

Indexed keywords

BACTERIAL PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PROTEIN BMRR; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS SUBTILIS; BACTERIAL GENE; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

BACILLUS SUBTILIS; BACTERIAL PROTEINS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; GENES, BACTERIAL; GENES, MDR; GENES, REGULATOR; HYDROGEN BONDING; LIGANDS; MEMBRANE TRANSPORT PROTEINS; MODELS, MOLECULAR; PROTEIN CONFORMATION;

EID: 79960578420     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1104850108     Document Type: Article

References (43)

1. Nikaido H (2009) Multidrug resistance in bacteria. Annu Rev Biochem 78:119-146.
2. Higgins CF (2007) Multiple molecular mechanisms for multidrug resistance transporters. Nature 446:749-757.
3. Grkovic S, Brown MH, Skurray RA (2002) Regulation of bacterial drug export systems. Microbiol Mol Biol Rev 66:671-701. (Pubitemid 35425113)
4. Gutmann DA, Ward A, Urbatsch IL, Chang G, van Veen HW (2010) Understanding polyspecificity of multidrug ABC transporters: Closing in on the gaps in ABCB1. Trends Biochem Sci 35:36-42.
5. Yang S, Lopez CR, Zechiedrich EL (2006) Quorum sensing and multidrug transporters in Escherichia coli. Proc Natl Acad Sci USA 103:2386-2391. (Pubitemid 43271679)
6. Heldwein EE, Brennan RG (2001) Crystal structure of the transcription activator BmrR bound to DNA and a drug. Nature 409:378-382. (Pubitemid 32151247)
7. Schumacher MA, et al. (2001) Structural mechanisms of QacR induction and multidrug recognition. Science 294:2158-2163. (Pubitemid 33150671)
8. Alguel Y, et al. (2007) Crystal structures of multidrug binding protein TtgR in complex with antibiotics and plant antimicrobials. J Mol Biol 369:829-840. (Pubitemid 46709926)
9. Yu EW, McDermott G, Zgurskaya HI, Nikaido H, Koshland DE (2003) Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 300:976-980. (Pubitemid 36548884)
10. Aller SG, et al. (2009) Structure of P-glycoprotein reveals a molecular basis for polyspecific drug binding. Science 323:1718-1722.
11. Ahmed M, Borsch CM, Taylor SS, Vazquez-Laslop N, Neyfakh AA (1994) A protein that activates expression of a multidrug efflux transporter upon binding the transporter substrates. J Biol Chem 269:28506-28513. (Pubitemid 24354599)
12. Newberry KJ, Brennan RG (2004) The structural mechanism for transcription activation by MerR family member multidrug transporter activation, N terminus. J Biol Chem 279:20356-20362. (Pubitemid 38623481)
13. Newberry KJ, et al. (2008) Structures of BmrR-drug complexes reveal a rigid multidrug binding pocket and transcription activation through Tyrosine expulsion. J Biol Chem 283:26795-26804.
14. Wade H (2010) MD recognition by MDR gene regulators. Curr Opin Struct Biol 20:489-496.
15. Brunger AT, et al. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54:905-921.
16. Dodson EJ, Winn M, Ralph A (1997) Collaborative Computational Project, number 4: Providing programs for protein crystallography. Methods Enzymol 277:620-633.
17. Adams PD, et al. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221.
18. Lawrence MC, Colman PM (1993) Shape complementarity at protein/protein interfaces. J Mol Biol 234:946-950. (Pubitemid 24027225)
19. Hugot M, et al. (2002) A structural basis for the activity of retro-Diels-Alder catalytic antibodies: Evidence for a catalytic aromatic residue. Proc Natl Acad Sci USA 99:9674-9678. (Pubitemid 34831106)
20. Li Y, Li H, Yang F, Smith-Gill SJ, Mariuzza RA (2003) X-ray snapshots of the maturation of an antibody response to a protein antigen. Nat Struct Biol 10:482-488. (Pubitemid 36637647)
21. Lewinson O, Adler J, Sigal N, Bibi E (2006) Promiscuity in multidrug recognition and transport: The bacterial MFS Mdr transporters. Mol Microbiol 61:277-284. (Pubitemid 44356562)
22. Peters KM, Sharbeen G, Theis T, Skurray RA, Brown MH (2009) Biochemical characterization of the multidrug regulator QacR distinguishes residues that are crucial to multidrug binding and induction of qacA transcription. Biochemistry 48:9794-9800.
23. Schumacher MA, Miller MC, Brennan RG (2004) Structural mechanism of the simultaneous binding of two drugs to a multidrug-binding protein. EMBO J 23:2923-2930. (Pubitemid 39093587)
24. Padlan EA (1990) On the nature of antibody combining sites: Unusual structural features that may confer on these sites an enhanced capacity for binding ligands. Proteins 7:112-124.
25. Mariuzza RA, Phillips SE, Poljak RJ (1987) The structural basis of antigen-antibody recognition. Annu Rev Biophys Biophys Chem 16:139-159.
26. Bianchet MA, et al. (1996) The three-dimensional structure of bovine odorant binding protein and its mechanism of odor recognition. Nat Struct Biol 3:934-939. (Pubitemid 26398326)
27. Fellouse FA, et al. (2005) Molecular recognition by a binary code. J Mol Biol 348:1153-1162. (Pubitemid 40602373)
28. Birtalan S, Fisher RD, Sidhu SS (2010) The functional capacity of the natural amino acids for molecular recognition. Mol Biosyst 6:1186-1194.
29. Chothia C (1976) Nature of accessible and buried surfaces in proteins. J Mol Biol 105:1-14.
30. Sharp KA, Nicholls A, Fine RF, Honig B (1991) Reconciling the magnitude of the microscopic and macroscopic hydrophobic effects. Science 252:106-109. (Pubitemid 21916946)
31. Wells JA, McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450:1001-1009. (Pubitemid 350273630)
32. Kuntz ID, Chen K, Sharp KA, Kollman PA (1999) The maximal affinity of ligands. Proc Natl Acad Sci USA 96:9997-10002. (Pubitemid 29422500)
33. Abad-Zapatero C (2007) Ligand efficiency indices for effective drug discovery. Expert Opin Drug Discov 2:469-488.
34. Barlow DJ, Thornton JM (1983) Ion-pairs in proteins. J Mol Biol 168:867-885.
35. Sharp KA, Honig B (1990) Electrostatic interactions in macromolecules: Theory and applications. Annu Rev Biophys Biophys Chem 19:301-332. (Pubitemid 20205627)
36. Mariuzza RA (2006) Multiple paths to multispecificity. Immunity 24:359-361.
37. Sobolev V, Sorokine A, Prilusky J, Abola EE, Edelman M (1999) Automated analysis of interatomic contacts in proteins. Bioinformatics 15:327-332. (Pubitemid 29213759)
38. Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8:127-134.
39. Bevington P, Robinson DK (1992) Data Reduction and Error Analysis for the Physical Sciences (McGraw-Hill, New York) p 328.
40. DeLano WL (2002) The Pymol Molecular Graphics System (DeLano Scientific, San Carlos, CA).
41. Binkowski TA, Naghibzadeh S, Liang J (2003) CASTp: Computed atlas of surface topography of proteins. Nucleic Acids Res 31:3352-3355. (Pubitemid 37442157)
42. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126-2132. (Pubitemid 41742764)
43. Davis IW, Murray LW, Richardson JS, Richardson DC (2004) MOLPROBITY: Structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res 32:W615-619.